Submitted by Anonymous (not verified) on 7 August 2024 - 12:00
Human medicines European public assessment report (EPAR): Adzynma, rADAMTS13, Date of authorisation: 01/08/2024, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Adzynma, rADAMTS13, Date of authorisation: 01/08/2024, Status: Authorised